TG Therapeutics【TGTX】株式ニュース

名称	銘柄コード	市場	種別
TG Therapeutics Inc	TGTX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	16.77	17:00:00

始値	安値	高値	終値	前日終値
				16.77

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/18	05:48	EDGAR2	Form 8-K - Current report
2024/6/18	04:08	EDGAR2	Form 144 - Report of proposed sale of securities
2024/6/11	00:23	EDGAR2	Form PX14A6G - Notice of exempt solicitation submitted by..
2024/6/07	20:50	GLOBE	TG Therapeutics to Participate in the Goldman Sachs 45th..
2024/6/03	20:30	GLOBE	TG Therapeutics to Participate in the Jefferies Global..
2024/5/31	20:30	GLOBE	TG Therapeutics Announces Presentations for BRIUMVI®..
2024/5/28	20:30	GLOBE	TG Therapeutics Announces Schedule of Upcoming Presentations..
2024/5/07	05:59	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/01	20:00	GLOBE	TG Therapeutics Provides Business Update and Reports First..
2024/5/01	05:55	GLOBE	TG Therapeutics to Host Conference Call on First Quarter..
2024/4/18	20:30	GLOBE	TG Therapeutics Announces Additional Data Presentations for..
2024/4/18	20:00	GLOBE	TG Therapeutics Awarded National Contract by the Department..
2024/4/15	20:30	GLOBE	TG Therapeutics Announces Presentation of Data for BRIUMVI®..
2024/3/08	21:30	GLOBE	TG Therapeutics Announces Schedule of Data Presentations for..
2024/3/01	21:30	GLOBE	TG Therapeutics Announces Presentation of Data for BRIUMVI®..
2024/3/01	07:23	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/28	21:24	EDGAR2	Form 8-K - Current report
2024/2/28	21:00	GLOBE	TG Therapeutics Provides Business Update and Reports Fourth..
2024/2/27	21:30	GLOBE	TG Therapeutics Announces Issuance of Additional Patents for..
2024/2/26	21:00	GLOBE	TG Therapeutics Announces European Launch of BRIUMVI®..
2024/2/23	21:30	GLOBE	TG Therapeutics to Host Conference Call on Fourth Quarter..
2024/2/20	21:30	GLOBE	TG Therapeutics Announces Schedule of Data Presentations for..
2024/2/15	11:53	EDGAR2	Form 5 - Annual statement of changes in beneficial ownership..
2024/2/15	05:30	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/27	06:23	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/10	21:37	EDGAR2	Form 8-K - Current report
2024/1/10	21:00	GLOBE	TG Therapeutics Provides Preliminary Fourth Quarter and Full..
2024/1/09	23:20	APS	Biotech Massively Bid Up Before Opening Bell
2024/1/09	21:00	GLOBE	TG Therapeutics Announces Global License Agreement with..
2024/1/09	08:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/09	08:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/06	07:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/06	01:02	EDGAR2	Form 144 - Report of proposed sale of securities
2024/1/05	21:30	GLOBE	TG Therapeutics to Participate in the 42nd Annual J.P...
2024/1/04	06:46	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/27	21:30	GLOBE	TG Therapeutics to Participate in the 6th Annual Evercore..
2023/11/07	07:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03	20:30	GLOBE	TG Therapeutics to Participate in the 5th Annual Guggenheim..
2023/11/01	20:33	EDGAR2	Form 8-K - Current report
2023/11/01	20:30	GLOBE	TG Therapeutics Provides Business Update and Reports Third..
2023/10/30	20:30	GLOBE	TG Therapeutics to Host Conference Call on Third Quarter..
2023/10/13	00:00	GLOBE	TG Therapeutics Announces Presentation of Data for BRIUMVI..
2023/10/11	23:30	GLOBE	TG Therapeutics Announces Presentation of Data for BRIUMVI..
2023/10/02	20:30	GLOBE	TG Therapeutics Announces Schedule of Data Presentations for..
2023/9/30	06:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/22	20:30	GLOBE	TG Therapeutics to Participate in the 2023 Cantor Global..
2023/9/07	20:30	GLOBE	TG Therapeutics to Participate in the H.C. Wainwright 25th..
2023/8/14	22:54	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/05	05:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/01	20:29	EDGAR2	Form 8-K - Current report